High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer

被引：0
|
作者：
Rongrong Wu
Ankit Patel
Yoshihisa Tokumaru
Mariko Asaoka
Masanori Oshi
Li Yan
Takashi Ishikawa
Kazuaki Takabe
机构：
[1] Department of Surgical Oncology,Department of Breast Surgery and Oncology
[2] Roswell Park Comprehensive Cancer Center,Department of Surgical Oncology, Graduate School of Medicine
[3] Tokyo Medical University,Department of Gastroenterological Surgery
[4] Gifu University,Department of Surgery, Jacobs School of Medicine and Biomedical Sciences
[5] Yokohama City University Graduate School of Medicine,Department of Surgery
[6] Department of Biostatistics & Bioinformatics,Department of Breast Surgery
[7] Roswell Park Comprehensive Cancer Center,undefined
[8] State University of New York,undefined
[9] Niigata University Graduate School of Medical and Dental Sciences,undefined
[10] Fukushima Medical University,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 193卷
关键词：
BRCA; Breast cancer; DNA repair; HRD; Neoadjuvant chemotherapy; RAD51;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：49 / 63
页数：14
相关论文
共 50 条
  • [21] ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer
    Elif Akisik
    Hulya Yazici
    Nejat Dalay
    Molecular Biology Reports, 2011, 38 : 343 - 348
  • [22] DNA repair protein RAD51 homolog 1 (RAD51), a potential prognostic biomarker and target for breast cancer
    Tang, Y-Q.
    Yap, W. H.
    Chia, A. Y. Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S235 - S236
  • [23] The significance of G/C polymorphism of the RAD51 gene in postmenopausal women with breast cancer
    Romanowicz-Makowska, Hanna
    Smolarz, Beata
    Sobczuk, Anna
    Pertynskl, Tomasz
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2008, 7 (01): : 38 - 41
  • [24] Polymorphisms in RAD51 and their relation with breast cancer in Saudi females
    Tulbah, Sahar
    Alabdulkarim, Huda
    Alanazi, Mohammad
    Parine, Narasimha Reddy
    Shaik, Jilani
    Pathan, Akbar Ali Khan
    Al-Amri, Abdullah
    Khan, Wajahatullah
    Warsy, Arjumand
    ONCOTARGETS AND THERAPY, 2016, 9 : 269 - 277
  • [25] BLM and RAD51 Genes Polymorphism and Susceptibility to Breast Cancer
    Sassi, Agnieszka
    Popielarski, Marcin
    Synowiec, Ewelina
    Morawiec, Zbigniew
    Wozniak, Katarzyna
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (03) : 451 - 459
  • [26] Identification of Rad51 alteration in patients with bilateral breast cancer
    Kato, M
    Yano, K
    Matsuo, F
    Saito, H
    Katagiri, T
    Kurumizaka, H
    Yoshimoto, M
    Kasumi, F
    Akiyama, F
    Sakamoto, G
    Nagawa, H
    Nakamura, Y
    Miki, Y
    JOURNAL OF HUMAN GENETICS, 2000, 45 (03) : 133 - 137
  • [27] Identification of Rad51 alteration in patients with bilateral breast cancer
    M. Kato
    K. Yano
    F. Matsuo
    H. Saito
    T. Katagiri
    H. Kurumizaka
    M. Yoshimoto
    F. Kasumi
    F. Akiyama
    G. Sakamoto
    H. Nagawa
    Y. Nakamura
    Y. Miki
    Journal of Human Genetics, 2000, 45 : 133 - 137
  • [28] Rad51 supports triple negative breast cancer metastasis
    Wiegmans, Adrian P.
    Al-Ejeh, Fares
    Chee, Nicole
    Yap, Pei-Yi
    Gorski, Julia J.
    Da Silva, Leonard
    Bolderson, Emma
    Chenevix-Trench, Georgia
    Anderson, Robin
    Simpson, Peter T.
    Lakhani, Sunil R.
    Khanna, Kum Kum
    ONCOTARGET, 2014, 5 (10) : 3261 - 3272
  • [29] Upregulation of RAD51 expression is associated with progression of thyroid carcinoma
    Sarwar, R.
    Sheikh, A. K.
    Mahjabeen, I.
    Bashir, K.
    Saeed, S.
    Kayani, M. A.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (03) : 446 - 454
  • [30] Angiopoietin pathway gene expression associated with poor breast cancer survival
    Ramanathan, Rajesh
    Olex, Amy L.
    Dozmorov, Mikhail
    Bear, Harry D.
    Fernandez, Leopoldo Jose
    Takabe, Kazuaki
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (01) : 191 - 198
12345